Submitted:
17 October 2025
Posted:
20 October 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design
2.3. Data Collection
2.4. Outcomes and Definitions
2.5. Statistical Analysis
3. Results
3.1. Baseline Characteristics
3.2. Postoperative Outcomes
4. Discussion
5. Conclusions
6. Limitations
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| CI CR-POPF DGE |
Confidence interval Clinically relevant postoperative pancreatic fistula Delayed gastric emptying |
| ERBD ENBD |
Endoscopic retrograde biliary drainage Endoscopic nasobiliary drainage |
| GIST HPB HR |
Gastrointestinal stromal tumor Hepatopancreatobiliary Hazard ratio |
| IVC ISGPF |
Inferior vena cava International Study Group on Pancreatic Fistula |
| ISGLS | International Study Group of Liver Surgery |
| ISGPS | International Study Group of Pancreatic Surgery |
| NCCN | National Comprehensive Cancer Network |
| NET | Neuroendocrine tumor |
| PBD | Preoperative biliary drainage |
| PD | Pancreaticoduodenectomy |
| PG | Pancreaticogastrostomy |
| PJ | Pancreaticojejunostomy |
| POBF POH |
Postoperative biliary fistula Postoperative hyperamylasemia |
| POPF PPAP |
Postoperative pancreatic fistula Postpancreatectomy acute pancreatitis |
| PPH | Post-pancreatectomy hemorrhage |
| PPPD | Pylorus-preserving pancreaticoduodenectomy |
| PTBD | Percutaneous transhepatic biliary drainage |
| PV | Portal vein |
| PV-SMV | Portal vein-superior mesenteric vein confluence |
| RCT | Randomized controlled trial |
| SD SE |
Standard deviation Standard error |
| SMV | Superior mesenteric vein |
| SSI | Surgical site infection |
| STROBE | STrengthening the Reporting of OBservational studies in Epidemiology |
| SV | Splenic vein |
| T-T | Termino-terminal |
References
- Cameron, J.L.; Riall, T.S.; Coleman, J.; Belcher, K.A. One Thousand Consecutive Pancreaticoduodenectomies. Ann Surg 2006, 244, 10–15. [CrossRef]
- Giuliani, T.; Marchegiani, G.; Di Gioia, A.; Amadori, B.; Perri, G.; Salvia, R.; Bassi, C. Patterns of Mortality after Pancreatoduodenectomy: A Root Cause, Day-to-Day Analysis. Surgery 2022, 172, 329–335. [CrossRef]
- Shahzad, N. Pancreaticojejunostomy versus Pancreaticogastrostomy after Pancreaticoduodenectomy to Prevent Post-Operative Pancreatic Fistula, a Dissonance between Evidence and Practice. Archives of Clinical Gastroenterology 2018, 008–011. [CrossRef]
- Yap, P.Y.; Hwang, J.S.; Bong, J.J. A Modified Technique of Pancreaticogastrostomy with Short Internal Stent: A Single Surgeon’s Experience. Asian J Surg 2018, 41, 250–256. [CrossRef]
- Lyu, Y.; Li, T.; Cheng, Y.; Wang, B.; Chen, L.; Zhao, S. Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy: An Up-to-Date Meta-Analysis of RCTs Applying the ISGPS (2016) Criteria. Surg Laparosc Endosc Percutan Tech 2018, 28, 139–146. [CrossRef]
- Bassi, C.; Marchegiani, G.; Dervenis, C.; Sarr, M.; Abu Hilal, M.; Adham, M.; Allen, P.; Andersson, R.; Asbun, H.J.; Besselink, M.G.; et al. The 2016 Update of the International Study Group (ISGPS) Definition and Grading of Postoperative Pancreatic Fistula: 11 Years After. Surgery 2017, 161, 584–591. [CrossRef]
- El Nakeeb, A.; Hamdy, E.; Sultan, A.M.; Salah, T.; Askr, W.; Ezzat, H.; Said, M.; Zeied, M.A.; Abdallah, T. Isolated Roux Loop Pancreaticojejunostomy versus Pancreaticogastrostomy after Pancreaticoduodenectomy: A Prospective Randomized Study. HPB 2014, 16, 713–722. [CrossRef]
- Hüttner, F.J.; Fitzmaurice, C.; Schwarzer, G.; Seiler, C.M.; Antes, G.; Büchler, M.W.; Diener, M.K. Pylorus-Preserving Pancreaticoduodenectomy (Pp Whipple) versus Pancreaticoduodenectomy (Classic Whipple) for Surgical Treatment of Periampullary and Pancreatic Carcinoma. Cochrane Database of Systematic Reviews 2016, 2016. [CrossRef]
- Diener, M.K.; Knaebel, H.-P.; Heukaufer, C.; Antes, G.; B??chler, M.W.; Seiler, C.M. A Systematic Review and Meta-Analysis of Pylorus-Preserving Versus Classical Pancreaticoduodenectomy for Surgical Treatment of Periampullary and Pancreatic Carcinoma. Ann Surg 2007, 245, 187–200. [CrossRef]
- F Feo, C. Wirsung Duct Occlusion Versus Pancreaticojejunostomy after Pancreaticoduodenectomy. International Journal of Surgery Research and Practice 2017, 4. [CrossRef]
- Marczell, A.P.; Stierer, M. Partial Pancreaticoduodenectomy (Whipple Procedure) for Pancreatic Malignancy: Occlusion of a Non-Anastomosed Pancreatic Stump with Fibrin Sealant. HPB Surg 1992, 5, 251–259; discussion 259-60. [CrossRef]
- Singh, K.; Kaman, L.; Tandup, C.; Raypattanaik, N.; Dahiya, D.; Behera, A. Internal Stenting across the Pancreaticojejunostomy and Main Pancreatic Duct after Pancreaticoduodenectomy. Polish Journal of Surgery 2021, 93, 40–47. [CrossRef]
- Zhou, Y.; Zhou, Q.; Li, Z.; Lin, Q.; Gong, Y.; Chen, R. The Impact of Internal or External Transanastomotic Pancreatic Duct Stents Following Pancreaticojejunostomy. Which One Is Better? A Meta-Analysis. Journal of Gastrointestinal Surgery 2012, 16, 2322–2335. [CrossRef]
- Bhoriwal, S.K.; Kumar, S.; Deo, S.; Sharma, J.; Mishra, A.; Kumar, N.; Saikia, J.; Dhall, K. Clinical Outcomes and Technical Description of Unstented End to Side Pancreaticogastrostomy by Small Posterior Gastrotomy. Ann Hepatobiliary Pancreat Surg 2021, 25, 251–258. [CrossRef]
- Peng, S.Y.; Wang, J.W.; Li, J.T.; Mou, Y.P.; Liu, Y.B.; Cai, X.J. Binding Pancreaticojejunostomy – a Safe and Reliable Anastomosis Procedure. HPB 2004, 6, 154–160. [CrossRef]
- Ohwada, S.; Ogawa, T.; Kawate, S.; Tanahashi, Y.; Iwazaki, S.; Tomizawa, N.; Yamada, T.; Ohya, T.; Morishita, Y. Results of Duct-To-Mucosa Pancreaticojejunostomy for Pancreaticoduodenectomy Billroth I Type Reconstruction in 100 Consecutive Patients. J Am Coll Surg 2001, 193, 29–35. [CrossRef]
- Bassi, C.; Falconi, M.; Molinari, E.; Salvia, R.; Butturini, G.; Sartori, N.; Mantovani, W.; Pederzoli, P. Reconstruction by Pancreaticojejunostomy Versus Pancreaticogastrostomy Following Pancreatectomy. Ann Surg 2005, 242, 767–773. [CrossRef]
- Topal, B.; Fieuws, S.; Aerts, R.; Weerts, J.; Feryn, T.; Roeyen, G.; Bertrand, C.; Hubert, C.; Janssens, M.; Closset, J. Pancreaticojejunostomy versus Pancreaticogastrostomy Reconstruction after Pancreaticoduodenectomy for Pancreatic or Periampullary Tumours: A Multicentre Randomised Trial. Lancet Oncol 2013, 14, 655–662. [CrossRef]
- Takano, S.; Ito, Y.; Watanabe, Y.; Yokoyama, T.; Kubota, N.; Iwai, S. Pancreaticojejunostomy versus Pancreaticogastrostomy in Reconstruction Following Pancreaticoduodenectomy. Journal of British Surgery 2000, 87, 423–427. [CrossRef]
- Wellner, U.F.; Sick, O.; Olschewski, M.; Adam, U.; Hopt, U.T.; Keck, T. Randomized Controlled Single-Center Trial Comparing Pancreatogastrostomy Versus Pancreaticojejunostomy After Partial Pancreatoduodenectomy. Journal of Gastrointestinal Surgery 2012, 16, 1686–1695. [CrossRef]
- Duffas, J.-P.; Suc, B.; Msika, S.; Fourtanier, G.; Muscari, F.; Hay, J.M.; Fingerhut, A.; Millat, B.; Radovanowic, A.; Fagniez, P.-L. A Controlled Randomized Multicenter Trial of Pancreatogastrostomy or Pancreatojejunostomy after Pancreatoduodenectomy. The American Journal of Surgery 2005, 189, 720–729. [CrossRef]
- Rault, A.; SaCunha, A.; Klopfenstein, D.; Larroudé, D.; Dobo Epoy, F.N.; Collet, D.; Masson, B. Pancreaticojejunal Anastomosis Is Preferable to Pancreaticogastrostomy after Pancreaticoduodenectomy for Longterm Outcomes of Pancreatic Exocrine Function. J Am Coll Surg 2005, 201, 239–244. [CrossRef]
- Keck, T.; Wellner, U.F.; Bahra, M.; Klein, F.; Sick, O.; Niedergethmann, M.; Wilhelm, T.J.; Farkas, S.A.; Börner, T.; Bruns, C.; et al. Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767). Ann Surg 2016, 263, 440–449. [CrossRef]
- Fernández-Cruz, L.; Cosa, R.; Blanco, L.; López-Boado, M.A.; Astudillo, E. Pancreatogastrostomy With Gastric Partition After Pylorus-Preserving Pancreatoduodenectomy Versus Conventional Pancreatojejunostomy. Ann Surg 2008, 248, 930–938. [CrossRef]
- Figueras, J.; Sabater, L.; Planellas, P.; Muñoz-Forner, E.; Lopez-Ben, S.; Falgueras, L.; Sala-Palau, C.; Albiol, M.; Ortega-Serrano, J.; Castro-Gutierrez, E. Randomized Clinical Trial of Pancreaticogastrostomy versus Pancreaticojejunostomy on the Rate and Severity of Pancreatic Fistula after Pancreaticoduodenectomy. British Journal of Surgery 2013, 100, 1597–1605. [CrossRef]
- Sanjay, P.; Takaori, K.; Govil, S.; Shrikhande, S. V; Windsor, J.A. ‘Artery-First’ Approaches to Pancreatoduodenectomy. British Journal of Surgery 2012, 99, 1027–1035. [CrossRef]
- Bassetti, M.; Eckmann, C.; Giacobbe, D.R.; Sartelli, M.; Montravers, P. Post-Operative Abdominal Infections: Epidemiology, Operational Definitions, and Outcomes. Intensive Care Med 2020, 46, 163–172. [CrossRef]
- Moreno, R.; Rhodes, A.; Piquilloud, L.; Hernandez, G.; Takala, J.; Gershengorn, H.B.; Tavares, M.; Coopersmith, C.M.; Myatra, S.N.; Singer, M.; et al. The Sequential Organ Failure Assessment (SOFA) Score: Has the Time Come for an Update? Crit Care 2023, 27, 15. [CrossRef]
- Feier, C.V.I.; Gaborean, V.; Faur, I.F.; Vonica, R.C.; Faur, A.M.; Rus, V.I.; Dragan, B.S.; Muntean, C. A Systematic Review of Closed-Incision Negative-Pressure Wound Therapy for Hepato-Pancreato-Biliary Surgery: Updated Evidence, Context, and Clinical Implications. J Clin Med 2025, 14, 5191. [CrossRef]
- Wente, M.N.; Veit, J.A.; Bassi, C.; Dervenis, C.; Fingerhut, A.; Gouma, D.J.; Izbicki, J.R.; Neoptolemos, J.P.; Padbury, R.T.; Sarr, M.G.; et al. Postpancreatectomy Hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) Definition. Surgery 2007, 142, 20–25. [CrossRef]
- Besselink, M.G.; van Rijssen, L.B.; Bassi, C.; Dervenis, C.; Montorsi, M.; Adham, M.; Asbun, H.J.; Bockhorn, M.; Strobel, O.; Büchler, M.W.; et al. Definition and Classification of Chyle Leak after Pancreatic Operation: A Consensus Statement by the International Study Group on Pancreatic Surgery. Surgery 2017, 161, 365–372. [CrossRef]
- Koch, M.; Garden, O.J.; Padbury, R.; Rahbari, N.N.; Adam, R.; Capussotti, L.; Fan, S.T.; Yokoyama, Y.; Crawford, M.; Makuuchi, M.; et al. Bile Leakage after Hepatobiliary and Pancreatic Surgery: A Definition and Grading of Severity by the International Study Group of Liver Surgery. Surgery 2011, 149, 680–688. [CrossRef]
- Wente, M.N.; Bassi, C.; Dervenis, C.; Fingerhut, A.; Gouma, D.J.; Izbicki, J.R.; Neoptolemos, J.P.; Padbury, R.T.; Sarr, M.G.; Traverso, L.W.; et al. Delayed Gastric Emptying (DGE) after Pancreatic Surgery: A Suggested Definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007, 142, 761–768. [CrossRef]
- Marchegiani, G.; Barreto, S.G.; Bannone, E.; Sarr, M.; Vollmer, C.M.; Connor, S.; Falconi, M.; Besselink, M.G.; Salvia, R.; Wolfgang, C.L.; et al. Postpancreatectomy Acute Pancreatitis (PPAP). Ann Surg 2022, 275, 663–672. [CrossRef]
- Mastalier, B.; Cauni, V.; Tihon, C.; Septimiu Petrutescu, M.; Ghita, B.; Popescu, V.; Andras, D.; Radu, I.M.; Vlasceanu, V.G.; Floroiu, M.F.; et al. Pancreaticogastrostomy versus Pancreaticojejunostomy and the Proposal of a New Postoperative Pancreatic Fistula Risk Score. J Clin Med 2023, 12, 6193. [CrossRef]
- Hallet, J.; Zih, F.S.W.; Deobald, R.G.; Scheer, A.S.; Law, C.H.L.; Coburn, N.G.; Karanicolas, P.J. The Impact of Pancreaticojejunostomy versus Pancreaticogastrostomy Reconstruction on Pancreatic Fistula after Pancreaticoduodenectomy: Meta-analysis of Randomized Controlled Trials. HPB 2015, 17, 113–122. [CrossRef]
- Wellner, U.F.; Sick, O.; Olschewski, M.; Adam, U.; Hopt, U.T.; Keck, T. Randomized Controlled Single-Center Trial Comparing Pancreatogastrostomy Versus Pancreaticojejunostomy After Partial Pancreatoduodenectomy. Journal of Gastrointestinal Surgery 2012, 16, 1686–1695. [CrossRef]
- Moldovan, S.A.; Moiș, E.I.; Graur, F.; Nechita, V.I.; Furcea, L.; Zaharie, F.; Bodea, R.; Mirel, S.; Moldovan, M. Ș.; Mocan, T.; et al. Biliary Drainage for the Preoperative Management of Periampullary Neoplasms: A Retrospective Cohort Study. Medicina (B Aires) 2025, 61, 1565. [CrossRef]
- Moldovan, S.A.; Moiș, E.I.; Graur, F.; Puia, I.C.; Vlad, I.; Nechita, V.I.; Furcea, L.; Zaharie, F.; Popa, C.; Leucuța, D.C.; et al. A Systematic Review and Meta-Analysis of Preoperative Biliary Drainage Methods in Periampullary Tumors. J Clin Med 2025, 14, 7097. [CrossRef]
- Cheng, Y.; Lai, M.; Wang, X.; Tu, B.; Cheng, N.; Gong, J. Pancreaticogastrostomy versus Pancreaticojejunostomy Reconstruction for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy. In Cochrane Database of Systematic Reviews; Cheng, Y., Ed.; John Wiley & Sons, Ltd: Chichester, UK, 2016.
- Wang, S.-E.; Chen, S.-C.; Shyr, B.-U.; Shyr, Y.-M. Comparison of Modified Blumgart Pancreaticojejunostomy and Pancreaticogastrostomy after Pancreaticoduodenectomy. HPB 2016, 18, 229–235. [CrossRef]



| Variable | All Patients (n = 604) | PG (n = 415) | PJ (n = 189) | p-value |
| Age, mean ± SD | 62.3 ± 10.4 | 63.6 ± 9.93 | 62.9 ± 9.84 | 0.442*** |
| Sex | 0.565* | |||
| Female | 250 (41.4%) | 175 (42.2%) | 75 (39.7%) | |
| Male | 354 (58.6%) | 240 (57.8%) | 114 (60.3%) | |
| Histology of lesion | 0.358* | |||
| Ampullary carcinoma | 124 (20.5%) | 94 (22.7%) | 30 (15.9%) | |
| Benign lesions | 22 (3.6%) | 18 (4.3%) | 4 (2.1%) | |
| Chronic pancreatitis | 18 (3.0%) | 12 (2.9%) | 6 (3.2%) | |
| Distal cholangiocarcinoma | 64 (10.6%) | 47 (11.3%) | 17 (9.0%) | |
| Duodenal carcinoma | 11 (1.8%) | 7 (1.7%) | 4 (2.1%) | |
| GIST | 8 (1.3%) | 6 (1.4%) | 2 (1.1%) | |
| NET | 23 (3.8%) | 16 (3.9%) | 7 (3.7%) | |
| Other carcinoma sites | 4 (0.7%) | 3 (0.7%) | 1 (0.5%) | |
| Pancreatic carcinoma | 316 (52.3%) | 205 (49.4%) | 111 (58.7%) | |
| Premalignant lesions | 14 (2.3%) | 7 (1.7%) | 7 (3.7%) | |
| Primary surgical procedure | 0.008* | |||
| PD | 569 (94.2%) | 398 (95.9%) | 171 (90.5%) | |
| PPPD | 35 (5.8%) | 17 (4.1%) | 18 (9.5%) | |
| Vascular invasion | 0.992** | |||
| IVC | 2 (0.3%) | 2 (0.5%) | 0 (0.0%) | |
| SMV | 17 (2.8%) | 12 (2.9%) | 5 (2.6%) | |
| PV | 20 (3.3%) | 13 (3.1%) | 7 (3.7%) | |
| PV+SMV | 3 (0.5%) | 2 (0.5%) | 1 (0.5%) | |
| no | 562 (93.0%) | 386 (93.0%) | 176 (93.1%) | |
| Vascular reconstruction | 1.000** | |||
| Tangential suture | 37 (90.2%) | 25 (89.3%) | 12 (92.3%) | |
| T-T anastomosis | 4 (9.8%) | 3 (10.7%) | 1 (7.7%) | |
| PBD | 0.701** | |||
| Endoscopic | 304 (50.3%) | 204 (49.2%) | 100 (52.9%) | |
| Percutaneous | 7 (1.2%) | 5 (1.2%) | 2 (1.1%) | |
| Surgical | 49 (8.1%) | 32 (7.7%) | 17 (9.0%) | |
| no | 244 (40.4%) | 174 (41.9%) | 70 (37.0%) | |
| Biliculture | 0.001** | |||
| Positive | 313 (51.8%) | 205 (49.4%) | 108 (57.1%) | |
| Negative | 152 (25.2%) | 123 (29.6%) | 29 (15.3%) | |
| no | 139 (23.0%) | 87 (21.0%) | 52 (27.5%) | |
| Operative time | 282.24 ± 68.33 | 284.90 ± 69.39 | 276.40 ± 65.73 | 0.155*** |
| Blood loss | 318.0 ±259.00 | 319.60 ±247.25 | 314.50 ±283.75 | 0.841*** |
| Variable | All Patients (n = 604) | PG (n = 415) | PJ (n = 189) | p-value |
| Overall complication rate | 271 (44.9%) | 182 (43.9%) | 89 (47.1%) | 0.481* |
| Wound infection | 28 (4.6%) | 19 (4.6%) | 9 (4.8%) | 0.921* |
| Intra-abdominal abscess | 45 (7.5%) | 30 (7.2%) | 15 (7.9%) | 0.759* |
| Sepsis | 17 (2.8%) | 11 (2.6%) | 6 (3.2%) | 0.689* |
| Clostridium difficile colitis | 42 (7.0%) | 30 (7.2%) | 12 (6.3%) | 0.693* |
| Pulmonary complications | 37 (6.1%) | 27 (6.5%) | 10 (5.3%) | 0.564* |
| Cardiovascular complications | 35 (5.8%) | 26 (6.3%) | 9 (4.8%) | 0.463* |
| PPAP | 23 (3.8%) | 17 (4.1%) | 6 (3.2%) | 0.583* |
| PPH | 89 (14.7%) | 65 (15.7%) | 24 (12.7%) | 0.341* |
| Lymph leakage | 12 (2.0%) | 6 (1.4%) | 6 (3.2%) | 0.158* |
| POPF | 86 (14.2%) | 51 (12.3%) | 35 (18.5%) | 0.042* |
| POBF | 24 (4.0%) | 12 (2.9%) | 12 (6.3%) | 0.044* |
| Gastrojejunostomy leakage | 7 (1.2%) | 3 (0.7%) | 4 (2.1%) | 0.138* |
| DGE | 44 (7.3%) | 30 (7.2%) | 14 (7.4%) | 0.938* |
| Celiac axis ischemia | 7 (1.2%) | 4 (1.0%) | 3 (1.6%) | 0.507* |
| Mesenteric infarction | 19 (3.1%) | 14 (3.4%) | 5 (2.6%) | 0.635* |
| Relaparotomy | 45 (7.5%) | 33 (8.0%) | 12 (6.3%) | 0.487* |
| Postoperative hospital stay, mean ± SD | 15.02± 10.84 | 14.60 ± 10.96 | 16.00 ± 10.52 | 0.135** |
| 90-day mortality | 56 (9.27%) | 37 (8.91%) | 19 (10.05%) | 0.768* |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).